How to Find the Best Tutors Quickly and Safely with the Award-Winning Tutor Circle

With parents placing greater emphasis on tutor credibility and transparency, Tutor Circle, a leading tutor matching platform based in Hong Kong, is strengthening its verification and quality-assurance measures to help parents confidently find qualified, reliable tutors for their children's upcoming spring school term in Hong Kong SAR and Singapore. “Parents want the reassurance that their […]

Trip.com Group Connects Content, Commerce, and Creators Through New “Trip Community” Ecosystem

As travellers increasingly look to content creators and communities for travel inspiration, Trip.com Group has unveiled Trip Community, a fully integrated travel-content ecosystem that brings together the Group's content and creator innovations to power seamless travel planning. The initiative builds on momentum from a series of creator engagements held throughout the year, including gatherings in

Hemogenyx Pharmaceuticals PLC – Issue of Equity

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN. LONDON,

Trip.com Group Connects Content, Commerce, and Creators Through New “Trip Community” Ecosystem

As travellers increasingly look to content creators and communities for travel inspiration, Trip.com Group has unveiled Trip Community, a fully integrated travel-content ecosystem that brings together the Group's content and creator innovations to power seamless travel planning. The initiative builds on momentum from a series of creator engagements held throughout the year, including gatherings in

Arrow Announces Appraisal Well M-HZ7 Results

Calgary, Alberta–(Newsfile Corp. – December 18, 2025) – Arrow Exploration Corp. (AIM: AXL) (TSXV: AXL) (“Arrow” or the “Company“), the high-growth operator with a portfolio of assets across key Colombian hydrocarbon basins, is pleased to provide an update on the operational activity at the Mateguafa Attic field on the Tapir Block in the Llanos Basin

DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS

Com Laude, the world's most successful domain name advisor to brands and enterprise businesses, reported that the application window for new Top-Level Domain names (“TLDs”) will be opened from April 30 to August 12, 2026 by the industry oversight body,ICANN.This announcement ends years of uncertainty, confirming that companies worldwide need to focus in Quarter 1

New Data from SkylineDx Demonstrates Merlin CP-GEP Test’s Superior Melanoma Risk Stratification

— New data analysis clarifies misleading benchmarks released by a competitor; separate SkylineDx analysis demonstrates Merlin CP-GEP Test provides stronger metastatic-risk stratification and superior predictive accuracy for SLNB outcomes compared to 31-GEP/i31-SLNB, when evaluated under harmonized and scientifically rigorous conditions — Recent publication in early-stage melanoma shows Merlin CP-GEP Test correctly identifies High-Risk patients with

Uxin Reports Unaudited Financial Results for the Quarter Ended September 30, 2025 and Announces Entry into Definitive Agreement for Financing

Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), China's leading used car retailer, today announced its unaudited financial results for the quarter ended September 30, 2025. Highlights for the Quarter Ended September 30, 2025 — Transaction volume was 15,904 units for the three months ended September 30, 2025, an increase of 37.0% from 11,606 units

GlucoModicum unveils Sofio(TM), the world’s first needle-free glucose monitor based on magneto-hydrodynamics (MHD)

PRESS RELEASE — FOR IMMEDIATE RELEASE GlucoModicum unveils Sofio(TM), the world's first needle-free glucose monitor based on magneto-hydrodynamics (MHD) MHD technology draws micro-sample through skin; glucose is measured using established electrochemical sensor technology Single-day sensor system offers periodic and personalized monitoring alternative to continuous glucose monitoring devices Extensive multi-year clinical studies (N>2,000) have demonstrated accuracy,

FoRx Therapeutics Announces USD 50M Series A Financing, Enabling Clinical Data Readout for Potential Best-in-Class PARG Inhibitor

Funding to support Phase 1 clinical development of best-in-class PARG inhibitor candidate FORX-428 FORX-428 is potential new treatment option for patients whose cancers are resistant to, or have become resistant to, PARP inhibitors Initial data expected in mid-2026 from open-label Phase 1 study in advanced solid tumors Basel, Switzerland – December 18, 2025 – FoRx

Scroll to Top